CompuGroup Medical SE: Release of a capital market information

DGAP Post-admission Duties announcement: CompuGroup Medical SE / Share Buyback CompuGroup Medical SE: Release of a capital market information 14.01.2019 / 09:34 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 4th Interim Announcement CompuGroup Medical SE / Share Buyback Koblenz, January 14, 2019 CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 4th Interim Announcement In the period from January 07, 2019, up to and including January 11, 2019, CompuGroup Medical SE has bought back a total of 41,651 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of December 14, 2018, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on December 17, 2018. The overall volume of the shares bought back daily in the period from Janaury 07, 2019, up to and including January 11, 2019, and the daily volume-weighted average stock market prices of the shares are as follows: Date Overall volume of Volume-weighted average shares bought back stock market price (number) (EUR, excluding ancillary costs of purchase, rounded to four places according to commercial practice) January 07, 2019 4,000 41.2438 January 08, 2019 12,450 40.9210 January 09, 2019 12,500 40.7176 January 10, 2019 8,500 41.3018 January 11, 2019 4,201 42.0480 In total: 41,651 41.0823 The total number of shares which have been bought back so far by CompuGroup Medical SE since December 17, 2018, up to and including January 11, 2019, within the framework of the share buyback program thus amounts to 107,224 no-par value shares. Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb. The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading). Koblenz, January 14, 2019 The Management Board CompuGroup Medical SE Investor Relations Maria Trost 21 56070 Koblenz, Germany T: 49 (0) 261 8000-6200 F: 49 (0) 261 8000-3200 14.01.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	CompuGroup Medical SE
	Maria Trost 21
	56070 Koblenz
	Germany
Internet:	www.cgm.com

End of News	DGAP News Service

765613  14.01.2019